Liver patients face hidden fungal threat – new study seeks answers
NCT ID NCT07238114
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at why people with severe liver disease who are in the intensive care unit (ICU) are at risk for a dangerous fungal lung infection called invasive pulmonary aspergillosis. Researchers will study 450 patients to find better ways to predict, diagnose, and treat this infection early. The goal is to improve survival and care for these critically ill patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUNGAL INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UZ Leuven
Leuven, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- A new procedure may offer relief for Cirrhosis-Related fluid buildup
- Can liver damage predict how drugs behave?
- Gut microbes may hold clues to sepsis organ injury
- Better crystal ball for liver crisis: new scores put to the test
- Can one Mega-Dose of an antifungal beat a deadly infection in AIDS patients?